Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEHZP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,595
Award facts
- Contract value 100% obligated
- $11,595.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,595.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on December 12, 2025, with an ultimate completion date of December 15, 2025, represents one of multiple orders placed under DMS Pharmaceutical Group's prime vendor contract. The award carries no set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is registered in the System for Award Management and maintains established relationships with the Defense Logistics Agency's Medical Supply Chain division, having received numerous delivery orders throughout 2025.
This delivery order falls under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent IDC, designated as contract SPE2DR and awarded November 13, 2025, carries a $499,999,999 ceiling and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. Under this contract vehicle, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, vaccines, and medical consumables to support Department of Defense military healthcare facilities worldwide. The company's product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, specialty surgical products, and routine pharmaceuticals, positioning it as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DU26FEHZP?
SPE2DU26FEHZP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DU26FEHZP worth?
The government has obligated $11,595 on SPE2DU26FEHZP.
Is contract SPE2DU26FEHZP an order under another contract?
Yes. SPE2DU26FEHZP is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEHZP competed?
The extent of competition for SPE2DU26FEHZP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award